Despite the important role of LL-37 in the initiation of psoriasis and the amplification of inflammation, to the best of our knowledge, the direct elimination of pathologically generated LL-37 has not been explored as a therapeutic approach for psoriasis. The gene discussed is CAMP; the disease is psoriasis.